PREA was implemented to address the significant gap in pediatric drug research. Historically, many medications prescribed to children were not specifically tested or approved for pediatric use, leading to off-label use and potentially unsafe dosing. By requiring studies in various pediatric age groups, PREA aims to ensure that medicines are appropriately tested and labeled for children.
